Constitutively Active Rhodopsin and Retinal Disease

Advances in Pharmacology

Volumn 70, Issue , 2014, Pages 1-36

  Park, Paul Shin Hyun ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 CIS RETINAL; APOPROTEIN; G PROTEIN COUPLED RECEPTOR; MUTANT PROTEIN; OPSIN; RETINA S ANTIGEN; RETINAL; RHODOPSIN; RHODOPSIN KINASE; TRANSDUCIN;

ARTICLE; CHROMATOPHORE; DARK ADAPTATION; EYE MALFORMATION; GENE MUTATION; HUMAN; HYDROGEN BOND; LEBER CONGENITAL AMAUROSIS; MOLECULAR INTERACTION; NIGHT BLINDNESS; NONHUMAN; PHENOTYPE; PHOTORECEPTOR CELL; PHOTOTRANSDUCTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RETINA DEGENERATION; RETINA DISEASE; RETINITIS PIGMENTOSA; RETINOL DEFICIENCY; THERMOSTABILITY; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; MUTATION;

ANIMALS; HUMANS; MUTATION; PHENOTYPE; RETINAL DISEASES; RHODOPSIN;

EID: 84902144481     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/B978-0-12-417197-8.00001-8     Document Type: Chapter

References (183)

1. Aho A.C., Donner K., Hyden C., Larsen L.O., Reuter T. Low retinal noise in animals with low body temperature allows high visual sensitivity. Nature 1988, 334:348-350.
2. Ahuja S., Smith S.O. Multiple switches in G protein-coupled receptor activation. Trends in Pharmacological Sciences 2009, 30:494-502.
3. al-Jandal N., Farrar G.J., Kiang A.S., Humphries M.M., Bannon N., Findlay J.B. A novel mutation within the rhodopsin gene (Thr-94-Ile) causing autosomal dominant congenital stationary night blindness. Human Mutation 1999, 13:75-81.
4. Angel T.E., Chance M.R., Palczewski K. Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:8555-8560.
5. Arnis S., Fahmy K., Hofmann K.P., Sakmar T.P. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. The Journal of Biological Chemistry 1994, 269:23879-23881.
6. Arnis S., Hofmann K.P. Two different forms of metarhodopsin II: Schiff base deprotonation precedes proton uptake and signaling state. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:7849-7853.
7. Arshavsky V.Y., Lamb T.D., Pugh E.N. G proteins and phototransduction. Annual Review of Physiology 2002, 64:153-187.
8. Batten M.L., Imanishi Y., Maeda T., Tu D.C., Moise A.R., Bronson D., et al. Lecithin-retinol acyltransferase is essential for accumulation of all-trans-retinyl esters in the eye and in the liver. The Journal of Biological Chemistry 2004, 279:10422-10432.
9. Baylor D. How photons start vision. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:560-565.
10. Baylor D.A., Lamb T.D., Yau K.W. Responses of retinal rods to single photons. Journal of Physiology 1979, 288:613-634.
11. Baylor D.A., Matthews G., Nunn B.J. Location and function of voltage-sensitive conductances in retinal rods of the salamander, Ambystoma tigrinum. Journal of Physiology 1984, 354:203-223.
12. Baylor D.A., Nunn B.J., Schnapf J.L. The photocurrent, noise and spectral sensitivity of rods of the monkey Macaca fascicularis. Journal of Physiology 1984, 357:575-607.
13. Becker R.S., Freedman K. A comprehensive investigation of the mechanism and photophysics of isomerization of a protonated and unprotonated Schiff-base of 11-cis-retinal. Journal of the American Chemical Society 1985, 107:1477-1485.
14. Bennett N., Sitaramayya A. Inactivation of photoexcited rhodopsin in retinal rods: The roles of rhodopsin kinase and 48-kDa protein (arrestin). Biochemistry 1988, 27:1710-1715.
15. Berson E.L. Retinitis pigmentosa. The Friedenwald lecture. Investigative Ophthalmology & Visual Science 1993, 34:1659-1676.
16. Burns M.E., Arshavsky V.Y. Beyond counting photons: Trials and trends in vertebrate visual transduction. Neuron 2005, 48:387-401.
17. Burns M.E., Baylor D.A. Activation, deactivation, and adaptation in vertebrate photoreceptor cells. Annual Review of Neuroscience 2001, 24:779-805.
18. Calvert P.D., Strissel K.J., Schiesser W.E., Pugh E.N., Arshavsky V.Y. Light-driven translocation of signaling proteins in vertebrate photoreceptors. Trends in Cell Biology 2006, 16:560-568.
19. Chen J., Shi G., Concepcion F.A., Xie G., Oprian D. Stable rhodopsin/arrestin complex leads to retinal degeneration in a transgenic mouse model of autosomal dominant retinitis pigmentosa. Journal of Neuroscience 2006, 26:11929-11937.
20. Choe H.W., Kim Y.J., Park J.H., Morizumi T., Pai E.F., Krauss N., et al. Crystal structure of metarhodopsin II. Nature 2011, 471:651-655.
21. Cohen G.B., Yang T., Robinson P.R., Oprian D.D. Constitutive activation of opsin: Influence of charge at position 134 and size at position 296. Biochemistry 1993, 32:6111-6115.
22. Cornwall M.C., Fain G.L. Bleached pigment activates transduction in isolated rods of the salamander retina. Journal of Physiology 1994, 480:261-279.
23. Crocker E., Eilers M., Ahuja S., Hornak V., Hirshfeld A., Sheves M., et al. Location of Trp265 in metarhodopsin II: Implications for the activation mechanism of the visual receptor rhodopsin. Journal of Molecular Biology 2006, 357:163-172.
24. Dalke C., Graw J. Mouse mutants as models for congenital retinal disorders. Experimental Eye Research 2005, 81:503-512.
25. Dartnall H.J. The photosensitivities of visual pigments in the presence of hydroxylamine. Vision Research 1968, 8:339-358.
26. den Hollander A.I., Roepman R., Koenekoop R.K., Cremers F.P. Leber congenital amaurosis: Genes, proteins and disease mechanisms. Progress in Retinal and Eye Research 2008, 27:391-419.
27. Deupi X., Edwards P., Singhal A., Nickle B., Oprian D., Schertler G., et al. Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:119-124.
28. Deupi X., Standfuss J., Schertler G. Conserved activation pathways in G-protein-coupled receptors. Biochemical Society Transactions 2012, 40:383-388.
29. Dizhoor A.M., Woodruff M.L., Olshevskaya E.V., Cilluffo M.C., Cornwall M.C., Sieving P.A., et al. Night blindness and the mechanism of constitutive signaling of mutant G90D rhodopsin. Journal of Neuroscience 2008, 28:11662-11672.
30. Dowling J.E., Wald G. Vitamin A deficiency and night blindness. Proceedings of the National Academy of Sciences of the United States of America 1958, 44:648-661.
31. Dowling J.E., Wald G. The biological function of vitamin A acid. Proceedings of the National Academy of Sciences of the United States of America 1960, 46:587-608.
32. Dryja T.P. Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture. American Journal of Ophthalmology 2000, 130:547-563.
33. Dryja T.P., Berson E.L., Rao V.R., Oprian D.D. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nature Genetics 1993, 4:280-283.
34. Dryja T.P., McGee T.L., Reichel E., Hahn L.B., Cowley G.S., Yandell D.W., et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990, 343:364-366.
35. Elias R.V., Sezate S.S., Cao W., McGinnis J.F. Temporal kinetics of the light/dark translocation and compartmentation of arrestin and alpha-transducin in mouse photoreceptor cells. Molecular Vision 2004, 10:672-681.
36. Emeis D., Kuhn H., Reichert J., Hofmann K.P. Complex formation between metarhodopsin II and GTP-binding protein in bovine photoreceptor membranes leads to a shift of the photoproduct equilibrium. FEBS Letters 1982, 143:29-34.
37. Ernst O.P., Lodowski D.T., Elstner M., Hegemann P., Brown L.S., Kandori H. Microbial and animal rhodopsins: Structures, functions, and molecular mechanisms. Chemical Reviews 2014, 114:126-163.
38. Fahmy K., Sakmar T.P., Siebert F. Transducin-dependent protonation of glutamic acid 134 in rhodopsin. Biochemistry 2000, 39:10607-10612.
39. Fahmy K., Zvyaga T.A., Sakmar T.P., Siebert F. Spectroscopic evidence for altered chromophore-protein interactions in low-temperature photoproducts of the visual pigment responsible for congenital night blindness. Biochemistry 1996, 35:15065-15073.
40. Fan J., Rohrer B., Frederick J.M., Baehr W., Crouch R.K. Rpe65-/- and Lrat-/- mice: Comparable models of Leber congenital amaurosis. Investigative Ophthalmology & Visual Science 2008, 49:2384-2389.
41. Fan J., Sakurai K., Chen C.K., Rohrer B., Wu B.X., Yau K.W., et al. Deletion of GRK1 causes retina degeneration through a transducin-independent mechanism. Journal of Neuroscience 2010, 30:2496-2503.
42. Fan J., Woodruff M.L., Cilluffo M.C., Crouch R.K., Fain G.L. Opsin activation of transduction in the rods of dark-reared Rpe65 knockout mice. Journal of Physiology 2005, 568:83-95.
43. Fritze O., Filipek S., Kuksa V., Palczewski K., Hofmann K.P., Ernst O.P. Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:2290-2295.
44. Galandrin S., Oligny-Longpre G., Bouvier M. The evasive nature of drug efficacy: Implications for drug discovery. Trends in Pharmacological Sciences 2007, 28:423-430.
45. Garriga P., Manyosa J. The eye photoreceptor protein rhodopsin. Structural implications for retinal disease. FEBS Letters 2002, 528:17-22.
46. Gozem S., Schapiro I., Ferre N., Olivucci M. The molecular mechanism of thermal noise in rod photoreceptors. Science 2012, 337:1225-1228.
47. Gross A.K., Rao V.R., Oprian D.D. Characterization of rhodopsin congenital night blindness mutant T94I. Biochemistry 2003, 42:2009-2015.
48. Gross A.K., Xie G., Oprian D.D. Slow binding of retinal to rhodopsin mutants G90D and T94D. Biochemistry 2003, 42:2002-2008.
49. Gu S.M., Thompson D.A., Srikumari C.R., Lorenz B., Finckh U., Nicoletti A., et al. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nature Genetics 1997, 17:194-197.
50. Han M., Smith S.O., Sakmar T.P. Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6. Biochemistry 1998, 37:8253-8261.
51. Hargrave P.A., McDowell J.H., Curtis D.R., Wang J.K., Juszczak E., Fong S.L., et al. The structure of bovine rhodopsin. Biophysics of Structure and Mechanism 1983, 9:235-244.
52. Hartong D.T., Berson E.L., Dryja T.P. Retinitis pigmentosa. Lancet 2006, 368:1795-1809.
53. Hecht S., Mandelbaum J. Rod-cone dark adaptation and vitamin A. Science 1938, 88:219-221.
54. Hecht S., Mandelbaum J. Dark adaptation and experimental human vitamin A deficiency. American Journal of Physiology 1940, 130:651-664.
55. Hecht S., Shlaer S., Pirenne M.H. Energy, quanta, and vision. Journal of General Physiology 1942, 25:819-840.
56. Hofmann K.P., Scheerer P., Hildebrand P.W., Choe H.W., Park J.H., Heck M., et al. A G protein-coupled receptor at work: The rhodopsin model. Trends in Biochemical Sciences 2009, 34:540-552.
57. Hu Y., Chen Y., Moiseyev G., Takahashi Y., Mott R., Ma J.X. Comparison of ocular pathologies in vitamin A-deficient mice and RPE65 gene knockout mice. Investigative Ophthalmology & Visual Science 2011, 52:5507-5514.
58. Jager F., Fahmy K., Sakmar T.P., Siebert F. Identification of glutamic acid 113 as the Schiff base proton acceptor in the metarhodopsin II photointermediate of rhodopsin. Biochemistry 1994, 33:10878-10882.
59. Jager S., Lewis J.W., Zvyaga T.A., Szundi I., Sakmar T.P., Kliger D.S. Time-resolved spectroscopy of the early photolysis intermediates of rhodopsin Schiff base counterion mutants. Biochemistry 1997, 36:1999-2009.
60. Janz J.M., Farrens D.L. Assessing structural elements that influence Schiff base stability: Mutants E113Q and D190N destabilize rhodopsin through different mechanisms. Vision Research 2003, 43:2991-3002.
61. Janz J.M., Fay J.F., Farrens D.L. Stability of dark state rhodopsin is mediated by a conserved ion pair in intradiscal loop E-2. The Journal of Biological Chemistry 2003, 278:16982-16991.
62. Jin S., Cornwall M.C., Oprian D.D. Opsin activation as a cause of congenital night blindness. Nature Neuroscience 2003, 6:731-735.
63. Kandori H., Shichida Y., Yoshizawa T. Photoisomerization in rhodopsin. Biochemistry (Mosc) 2001, 66:1197-1209.
64. Kaushal S., Khorana H.G. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 1994, 33:6121-6128.
65. Kawamura S., Colozo A.T., Ge L., Muller D.J., Park P.S. Structural, energetic, and mechanical perturbations in rhodopsin mutant that causes congenital stationary night blindness. The Journal of Biological Chemistry 2012, 287:21826-21835.
66. Kawamura S., Gerstung M., Colozo A.T., Helenius J., Maeda A., Beerenwinkel N., et al. Kinetic, energetic, and mechanical differences between dark-state rhodopsin and opsin. Structure 2013, 21:426-437.
67. Keen T.J., Inglehearn C.F., Lester D.H., Bashir R., Jay M., Bird A.C., et al. Autosomal dominant retinitis pigmentosa: Four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics 1991, 11:199-205.
68. Kenakin T. Collateral efficacy in drug discovery: Taking advantage of the good (allosteric) nature of 7TM receptors. Trends in Pharmacological Sciences 2007, 28:407-415.
69. Kennedy M.J., Lee K.A., Niemi G.A., Craven K.B., Garwin G.G., Saari J.C., et al. Multiple phosphorylation of rhodopsin and the in vivo chemistry underlying rod photoreceptor dark adaptation. Neuron 2001, 31:87-101.
70. Kibelbek J., Mitchell D.C., Beach J.M., Litman B.J. Functional equivalence of metarhodopsin II and the Gt-activating form of photolyzed bovine rhodopsin. Biochemistry 1991, 30:6761-6768.
71. Kim J.M., Altenbach C., Kono M., Oprian D.D., Hubbell W.L., Khorana H.G. Structural origins of constitutive activation in rhodopsin: Role of the K296/E113 salt bridge. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:12508-12513.
72. Kim J.M., Altenbach C., Thurmond R.L., Khorana H.G., Hubbell W.L. Structure and function in rhodopsin: Rhodopsin mutants with a neutral amino acid at E134 have a partially activated conformation in the dark state. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:14273-14278.
73. Kim T.H., Chung K.Y., Manglik A., Hansen A.L., Dror R.O., Mildorf T.J., et al. The role of ligands on the equilibria between functional states of a G protein-coupled receptor. Journal of the American Chemical Society 2013, 135:9465-9474.
74. Kiser P.D., Golczak M., Maeda A., Palczewski K. Key enzymes of the retinoid (visual) cycle in vertebrate retina. Biochimica et Biophysica Acta 2011, 1821:137-151.
75. Knierim B., Hofmann K.P., Ernst O.P., Hubbell W.L. Sequence of late molecular events in the activation of rhodopsin. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:20290-20295.
76. Kobilka B.K., Deupi X. Conformational complexity of G-protein-coupled receptors. Trends in Pharmacological Sciences 2007, 28:397-406.
77. Leber T. Ueber Retinitis pigmentosa und angeborene Amaurose. Graefe's Archive for Clinical and Experimental Ophthalmology 1869, 15:1-25.
78. Leff P. The two-state model of receptor activation. Trends in Pharmacological Sciences 1995, 16:89-97.
79. Leioatts N., Mertz B., Martinez-Mayorga K., Romo T.D., Pitman M.C., Feller S.E., et al. Retinal ligand mobility explains internal hydration and reconciles active rhodopsin structures. Biochemistry 2014, 53:376-385.
80. Lem J., Fain G.L. Constitutive opsin signaling: Night blindness or retinal degeneration?. Trends in Molecular Medicine 2004, 10:150-157.
81. Li J., Edwards P.C., Burghammer M., Villa C., Schertler G.F. Structure of bovine rhodopsin in a trigonal crystal form. Journal of Molecular Biology 2004, 343:1409-1438.
82. Li T., Franson W.K., Gordon J.W., Berson E.L., Dryja T.P. Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:3551-3555.
83. Liu J.J., Horst R., Katritch V., Stevens R.C., Wuthrich K. Biased signaling pathways in beta2-adrenergic receptor characterized by 19F-NMR. Science 2012, 335:1106-1110.
84. Liu J., Liu M.Y., Fu L., Zhu G.A., Yan E.C. Chemical kinetic analysis of thermal decay of rhodopsin reveals unusual energetics of thermal isomerization and hydrolysis of Schiff base. The Journal of Biological Chemistry 2011, 286:38408-38416.
85. Liu M.Y., Liu J., Mehrotra D., Liu Y., Guo Y., Baldera-Aguayo P.A., et al. Thermal stability of rhodopsin and progression of retinitis pigmentosa: Comparison of S186W and D190N rhodopsin mutants. The Journal of Biological Chemistry 2013, 288:17698-17712.
86. Lorenz-Fonfria V.A., Furutani Y., Ota T., Ido K., Kandori H. Protein fluctuations as the possible origin of the thermal activation of rod photoreceptors in the dark. Journal of the American Chemical Society 2010, 132:5693-5703.
87. Ludeke S., Beck M., Yan E.C., Sakmar T.P., Siebert F., Vogel R. The role of Glu181 in the photoactivation of rhodopsin. Journal of Molecular Biology 2005, 353:345-356.
88. Luo D.G., Yue W.W., Ala-Laurila P., Yau K.W. Activation of visual pigments by light and heat. Science 2011, 332:1307-1312.
89. Mahalingam M., Martinez-Mayorga K., Brown M.F., Vogel R. Two protonation switches control rhodopsin activation in membranes. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:17795-17800.
90. Malanson K.M., Lem J. Rhodopsin-mediated retinitis pigmentosa. Progress in Molecular Biology and Translational Science 2009, 88:1-31.
91. Malik R.U., Ritt M., DeVree B.T., Neubig R.R., Sunahara R.K., Sivaramakrishnan S. Detection of G protein-selective G protein-coupled receptor (GPCR) conformations in live cells. The Journal of Biological Chemistry 2013, 288:17167-17178.
92. Marlhens F., Bareil C., Griffoin J.M., Zrenner E., Amalric P., Eliaou C., et al. Mutations in RPE65 cause Leber's congenital amaurosis. Nature Genetics 1997, 17:139-141.
93. Martinez-Mayorga K., Pitman M.C., Grossfield A., Feller S.E., Brown M.F. Retinal counterion switch mechanism in vision evaluated by molecular simulations. Journal of the American Chemical Society 2006, 128:16502-16503.
94. Matias-Florentino M., Ayala-Ramirez R., Graue-Wiechers F., Zenteno J.C. Molecular screening of rhodopsin and peripherin/RDS genes in Mexican families with autosomal dominant retinitis pigmentosa. Current Eye Research 2009, 34:1050-1056.
95. Matthews R.G., Hubbard R., Brown P.K., Wald G. Tautomeric forms of metarhodopsin. Journal of General Physiology 1963, 47:215-240.
96. McDowell J.H., Nawrocki J.P., Hargrave P.A. Phosphorylation sites in bovine rhodopsin. Biochemistry 1993, 32:4968-4974.
97. Melia T.J., Cowan C.W., Angleson J.K., Wensel T.G. A comparison of the efficiency of G protein activation by ligand-free and light-activated forms of rhodopsin. Biophysical Journal 1997, 73:3182-3191.
98. Mendes H.F., van der Spuy J., Chapple J.P., Cheetham M.E. Mechanisms of cell death in rhodopsin retinitis pigmentosa: Implications for therapy. Trends in Molecular Medicine 2005, 11:177-185.
99. Mendez A., Burns M.E., Roca A., Lem J., Wu L.W., Simon M.I., et al. Rapid and reproducible deactivation of rhodopsin requires multiple phosphorylation sites. Neuron 2000, 28:153-164.
100. Mendez A., Lem J., Simon M., Chen J. Light-dependent translocation of arrestin in the absence of rhodopsin phosphorylation and transducin signaling. Journal of Neuroscience 2003, 23:3124-3129.
101. Mirzadegan T., Benko G., Filipek S., Palczewski K. Sequence analyses of G-protein-coupled receptors: Similarities to rhodopsin. Biochemistry 2003, 42:2759-2767.
102. Moaven H., Koike Y., Jao C.C., Gurevich V.V., Langen R., Chen J. Visual arrestin interaction with clathrin adaptor AP-2 regulates photoreceptor survival in the vertebrate retina. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:9463-9468.
103. Naash M.I., Wu T.H., Chakraborty D., Fliesler S.J., Ding X.Q., Nour M., et al. Retinal abnormalities associated with the G90D mutation in opsin. Journal of Comparative Neurology 2004, 478:149-163.
104. Nakamichi H., Okada T. Crystallographic analysis of primary visual photochemistry. Angewandte Chemie International Edition in English 2006, 45:4270-4273.
105. Nakamichi H., Okada T. Local peptide movement in the photoreaction intermediate of rhodopsin. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:12729-12734.
106. Nash Z.A., Naash M.I. Light/dark translocation of alphatransducin in mouse photoreceptor cells expressing G90D mutant opsin. Advances in Experimental Medicine and Biology 2006, 572:125-131.
107. Nathans J., Hogness D.S. Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin. Cell 1983, 34:807-814.
108. Nathans J., Hogness D.S. Isolation and nucleotide sequence of the gene encoding human rhodopsin. Proceedings of the National Academy of Sciences of the United States of America 1984, 81:4851-4855.
109. Nathans J., Merbs S.L., Sung C.H., Weitz C.J., Wang Y. Molecular genetics of human visual pigments. Annual Review of Genetics 1992, 26:403-424.
110. Neidhardt J., Barthelmes D., Farahmand F., Fleischhauer J.C., Berger W. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes. Investigative Ophthalmology & Visual Science 2006, 47:1630-1635.
111. Nygaard R., Frimurer T.M., Holst B., Rosenkilde M.M., Schwartz T.W. Ligand binding and micro-switches in 7TM receptor structures. Trends in Pharmacological Sciences 2009, 30:249-259.
112. Ohguro H., Johnson R.S., Ericsson L.H., Walsh K.A., Palczewski K. Control of rhodopsin multiple phosphorylation. Biochemistry 1994, 33:1023-1028.
113. Okada T., Ernst O.P., Palczewski K., Hofmann K.P. Activation of rhodopsin: New insights from structural and biochemical studies. Trends in Biochemical Sciences 2001, 26:318-324.
114. Okada T., Fujiyoshi Y., Silow M., Navarro J., Landau E.M., Shichida Y. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:5982-5987.
115. Ovchinnikov Yu A. Rhodopsin and bacteriorhodopsin: Structure-function relationships. FEBS Letters 1982, 148:179-191.
116. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289:739-745.
117. Papac D.I., Oatis J.E., Crouch R.K., Knapp D.R. Mass spectrometric identification of phosphorylation sites in bleached bovine rhodopsin. Biochemistry 1993, 32:5930-5934.
118. Pardo L., Deupi X., Dolker N., Lopez-Rodriguez M.L., Campillo M. The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors. ChemBioChem 2007, 8:19-24.
119. Park P.S. Ensemble of G protein-coupled receptor active states. Current Medicinal Chemistry 2012, 19:1146-1154.
120. Park J.H., Morizumi T., Li Y., Hong J.E., Pai E.F., Hofmann K.P., et al. Opsin, a structural model for olfactory receptors?. Angewandte Chemie International Edition in English 2013, 52:11021-11024.
121. Park J.H., Scheerer P., Hofmann K.P., Choe H.W., Ernst O.P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008, 454:183-187.
122. Perez D.M., Karnik S.S. Multiple signaling states of G-protein-coupled receptors. Pharmacological Reviews 2005, 57:147-161.
123. Rajagopal S., Rajagopal K., Lefkowitz R.J. Teaching old receptors new tricks: Biasing seven-transmembrane receptors. Nature Reviews. Drug Discovery 2010, 9:373-386.
124. Ramon E., del Valle L.J., Garriga P. Unusual thermal and conformational properties of the rhodopsin congenital night blindness mutant Thr-94 ->Ile. The Journal of Biological Chemistry 2003, 278:6427-6432.
125. Rao V.R., Cohen G.B., Oprian D.D. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 1994, 367:639-642.
126. Redmond T.M., Yu S., Lee E., Bok D., Hamasaki D., Chen N., et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nature Genetics 1998, 20:344-351.
127. Ridge K.D., Abdulaev N.G., Sousa M., Palczewski K. Phototransduction: Crystal clear. Trends in Biochemical Science 2003, 28:479-487.
128. Rim J., Oprian D.D. Constitutive activation of opsin: Interaction of mutants with rhodopsin kinase and arrestin. Biochemistry 1995, 34:11938-11945.
129. Ritter E., Elgeti M., Bartl F.J. Activity switches of rhodopsin. Photochemistry and Photobiology 2008, 84:911-920.
130. Robinson P.R., Cohen G.B., Zhukovsky E.A., Oprian D.D. Constitutively active mutants of rhodopsin. Neuron 1992, 9:719-725.
131. Ruprecht J.J., Mielke T., Vogel R., Villa C., Schertler G.F. Electron crystallography reveals the structure of metarhodopsin I. The EMBO Journal 2004, 23:3609-3620.
132. Ruther K., von Ballestrem C.L., Muller A., Kremmer S., Eckstein A., Apfelstedt-Sylla E., et al. Clinical features of autosomal dominant retinitis pigmentosa with the Ser186Trp mutation of rhodopsin. Degenerative diseases of the retina 1995, 303-312. Plenum Press, New York. R.E. Anderson, M.M. LaVail, J.G. Hollyfield (Eds.).
133. Saari J.C. Vitamin A metabolism in rod and cone visual cycles. Annual Review of Nutrition 2012, 32:125-145.
134. Sakmar T.P., Franke R.R., Khorana H.G. Glutamic acid-113 serves as the retinylidene Schiff base counterion in bovine rhodopsin. Proceedings of the National Academy of Sciences of the United States of America 1989, 86:8309-8313.
135. Salom D., Lodowski D.T., Stenkamp R.E., Le Trong I., Golczak M., Jastrzebska B., et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:16123-16128.
136. Samama P., Cotecchia S., Costa T., Lefkowitz R.J. A mutation-induced activated state of the b2-adrenergic receptor. Extending the ternary complex model. The Journal of Biological Chemistry 1993, 268:4625-4636.
137. Sancho-Pelluz J., Tosi J., Hsu C.W., Lee F., Wolpert K., Tabacaru M.R., et al. Mice with a D190N mutation in the gene encoding rhodopsin: A model for human autosomal-dominant retinitis pigmentosa. Molecular Medicine 2012, 18:549-555.
138. Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krauss N., Choe H.W., et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 2008, 455:497-502.
139. Schertler G.F., Villa C., Henderson R. Projection structure of rhodopsin. Nature 1993, 362:770-772.
140. Seifert R. Functional selectivity of G-protein-coupled receptors: From recombinant systems to native human cells. Biochemical Pharmacology 2013, 86:853-861.
141. Shi L., Liapakis G., Xu R., Guarnieri F., Ballesteros J.A., Javitch J.A. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. The Journal of Biological Chemistry 2002, 277:40989-40996.
142. Shi W., Sports C.D., Raman D., Shirakawa S., Osawa S., Weiss E.R. Rhodopsin arginine-135 mutants are phosphorylated by rhodopsin kinase and bind arrestin in the absence of 11-cis-retinal. Biochemistry 1998, 37:4869-4874.
143. Shichida Y., Imai H. Visual pigment: G-protein-coupled receptor for light signals. Cellular and Molecular Life Sciences 1998, 54:1299-1315.
144. Shintani K., Shechtman D.L., Gurwood A.S. Review and update: Current treatment trends for patients with retinitis pigmentosa. Optometry 2009, 80:384-401.
145. Sieving P.A., Fowler M.L., Bush R.A., Machida S., Calvert P.D., Green D.G., et al. Constitutive "light" adaptation in rods from G90D rhodopsin: A mechanism for human congenital nightblindness without rod cell loss. Journal of Neuroscience 2001, 21:5449-5460.
146. Sieving P.A., Richards J.E., Naarendorp F., Bingham E.L., Scott K., Alpern M. Dark-light: Model for nightblindness from the human rhodopsin Gly-90->Asp mutation. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:880-884.
147. Singhal A., Ostermaier M.K., Vishnivetskiy S.A., Panneels V., Homan K.T., Tesmer J.J., et al. Insights into congenital stationary night blindness based on the structure of G90D rhodopsin. EMBO Reports 2013, 14:520-526.
148. Slepak V.Z., Hurley J.B. Mechanism of light-induced translocation of arrestin and transducin in photoreceptors: Interaction-restricted diffusion. IUBMB Life 2008, 60:2-9.
149. Sokolov M., Lyubarsky A.L., Strissel K.J., Savchenko A.B., Govardovskii V.I., Pugh E.N., et al. Massive light-driven translocation of transducin between the two major compartments of rod cells: A novel mechanism of light adaptation. Neuron 2002, 34:95-106.
150. 5 muscarinic receptor by a series of mutations at the extracellular end of transmembrane 6. Biochemistry 1997, 36:10109-10116.
151. Standfuss J., Edwards P.C., D'Antona A., Fransen M., Xie G., Oprian D.D., et al. The structural basis of agonist-induced activation in constitutively active rhodopsin. Nature 2011, 471:656-660.
152. Stojanovic A., Hwa J. Rhodopsin and retinitis pigmentosa: Shedding light on structure and function. Receptors & Channels 2002, 8:33-50.
153. Stryer L. Visual excitation and recovery. The Journal of Biological Chemistry 1991, 266:10711-10714.
154. Sullivan J.M., Scott K.M., Falls H.F., Richards J.E., Sieving P.A. A novel rhodopsin mutation at the retinal binding site (Lys-296-Met) in ADRP. Investigative Ophthalmology & Visual Science 1993, 34:1149.
155. Sung C.H., Davenport C.M., Hennessey J.C., Maumenee I.H., Jacobson S.G., Heckenlively J.R., et al. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:6481-6485.
156. Tang P.H., Kono M., Koutalos Y., Ablonczy Z., Crouch R.K. New insights into retinoid metabolism and cycling within the retina. Progress in Retinal and Eye Research 2013, 32:48-63.
157. Thompson P., Findlay J.B. Phosphorylation of ovine rhodopsin. Identification of the phosphorylated sites. Biochemical Journal 1984, 220:773-780.
158. Thompson D.A., Li Y., McHenry C.L., Carlson T.J., Ding X., Sieving P.A., et al. Mutations in the gene encoding lecithin retinol acyltransferase are associated with early-onset severe retinal dystrophy. Nature Genetics 2001, 28:123-124.
159. Toledo D., Ramon E., Aguila M., Cordomi A., Perez J.J., Mendes H.F., et al. Molecular mechanisms of disease for mutations at gly-90 in rhodopsin. The Journal of Biological Chemistry 2011, 286:39993-40001.
160. Travis G.H., Golczak M., Moise A.R., Palczewski K. Diseases caused by defects in the visual cycle: Retinoids as potential therapeutic agents. Annual Review of Pharmacology and Toxicology 2007, 47:469-512.
161. Trzaskowski B., Latek D., Yuan S., Ghoshdastider U., Debinski A., Filipek S. Action of molecular switches in GPCRs-Theoretical and experimental studies. Current Medicinal Chemistry 2012, 19:1090-1109.
162. Tsui I., Chou C.L., Palmer N., Lin C.S., Tsang S.H. Phenotype-genotype correlations in autosomal dominant retinitis pigmentosa caused by RHO, D190N. Current Eye Research 2008, 33:1014-1022.
163. Tsukamoto H., Farrens D.L. A constitutively activating mutation alters the dynamics and energetics of a key conformational change in a ligand-free G protein-coupled receptor. The Journal of Biological Chemistry 2013, 288:28207-28216.
164. Urban J.D., Clarke W.P., von Zastrow M., Nichols D.E., Kobilka B., Weinstein H., et al. Functional selectivity and classical concepts of quantitative pharmacology. Journal of Pharmacology and Experimental Therapeutics 2007, 320:1-13.
165. Vaithinathan R., Berson E.L., Dryja T.P. Further screening of the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. Genomics 1994, 21:461-463.
166. Vishnivetskiy S.A., Ostermaier M.K., Singhal A., Panneels V., Homan K.T., Glukhova A., et al. Constitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 binding. Cellular Signalling 2013, 25:2155-2162.
167. Vishnivetskiy S.A., Raman D., Wei J., Kennedy M.J., Hurley J.B., Gurevich V.V. Regulation of arrestin binding by rhodopsin phosphorylation level. The Journal of Biological Chemistry 2007, 282:32075-32083.
168. Vogel R., Siebert F. Conformations of the active and inactive states of opsin. The Journal of Biological Chemistry 2001, 276:38487-38493.
169. Wacker D., Wang C., Katritch V., Han G.W., Huang X.P., Vardy E., et al. Structural features for functional selectivity at serotonin receptors. Science 2013, 340:615-619.
170. Wald G. Molecular basis of visual excitation. Science 1968, 162:230-239.
171. Wald G., Brown P.K. The molar extinction of rhodopsin. Journal of General Physiology 1953, 37:189-200.
172. Wald G., Jeghers H., Arminio J. An experiment in human dietary night-blindness. American Journal of Physiology 1938, 123:732-746.
173. Wald G., Steven D. An experiment in human vitamin A-deficiency. Proceedings of the National Academy of Sciences of the United States of America 1939, 25:344-349.
174. Woodruff M.L., Wang Z., Chung H.Y., Redmond T.M., Fain G.L., Lem J. Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis. Nature Genetics 2003, 35:158-164.
175. Yan E.C., Kazmi M.A., Ganim Z., Hou J.M., Pan D., Chang B.S., et al. Retinal counterion switch in the photoactivation of the G protein-coupled receptor rhodopsin. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:9262-9267.
176. Yang T., Snider B.B., Oprian D.D. Synthesis and characterization of a novel retinylamine analog inhibitor of constitutively active rhodopsin mutants found in patients with autosomal dominant retinitis pigmentosa. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:13559-13564.
177. Yau K.W., Hardie R.C. Phototransduction motifs and variations. Cell 2009, 139:246-264.
178. Yau K.W., Matthews G., Baylor D.A. Thermal activation of the visual transduction mechanism in retinal rods. Nature 1979, 279:806-807.
179. Ye S., Zaitseva E., Caltabiano G., Schertler G.F., Sakmar T.P., Deupi X., et al. Tracking G-protein-coupled receptor activation using genetically encoded infrared probes. Nature 2010, 464:1386-1389.
180. Zeitz C., Gross A.K., Leifert D., Kloeckener-Gruissem B., McAlear S.D., Lemke J., et al. Identification and functional characterization of a novel rhodopsin mutation associated with autosomal dominant CSNB. Investigative Ophthalmology & Visual Science 2008, 49:4105-4114.
181. Zhang H., Huang W., Zhu X., Craft C.M., Baehr W., Chen C.K. Light-dependent redistribution of visual arrestins and transducin subunits in mice with defective phototransduction. Molecular Vision 2003, 9:231-237.
182. Zhukovsky E.A., Oprian D.D. Effect of carboxylic acid side chains on the absorption maximum of visual pigments. Science 1989, 246:928-930.
183. Zvyaga T.A., Fahmy K., Siebert F., Sakmar T.P. Characterization of the mutant visual pigment responsible for congenital night blindness: A biochemical and Fourier-transform infrared spectroscopy study. Biochemistry 1996, 35:7536-7545.